Recursion Pharmaceuticals Stock Forecast

Buy candidate since Jun 25, 2026 Gain 5.39%

The Recursion Pharmaceuticals, Inc. stock price gained 5.39% on the last trading day (Friday, 26th Jun 2026), rising from $3.34 to $3.52. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 10.37% from a day low at $3.28 to a day high of $3.62. The price has risen in 5 of the last 10 days and is up by 11.75% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 27 million more shares were traded than the day before. In total, 43 million shares were bought and sold for approximately $149.91 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Recursion Pharmaceuticals, Inc. stock with a 90% probability to be traded between $2.77 and $3.72 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

RXRX Signals & Forecast

The Recursion Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.25 and $3.23. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 15.79%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Recursion Pharmaceuticals, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $3.23 and $3.15. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Recursion Pharmaceuticals, Inc. finds support just below today's level at $3.23. If this is broken, then the next support from accumulated volume will be at $3.15 and $3.11.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.340 between high and low, or 10.37%. For the last week, the stock has had daily average volatility of 7.17%.

Our recommended stop-loss: $3.38 (-3.84%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 11 days ago.)

Trading Expectations (RXRX) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Recursion Pharmaceuticals, Inc. to open at $3.47, and during the day (based on 14 day Average True Range), to move between $3.40 and $3.64, which gives a possible trading interval of +/-$0.246 (+/-7.23%) up or down from last closing price. If Recursion Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 7.23% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.59 (1.99%) than the support at $3.23 (8.24%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Recursion Pharmaceuticals, Inc. stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Recursion Pharmaceuticals, Inc. stock to perform well in the short-term period.

Current score: 3.556 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $3.47 ( 1.33%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk